Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online October 1, 2007
Diabetes 57:306-314, 2008
DOI: 10.2337/db07-0381
© 2008 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online-Only Appendix
Right arrow All Versions of this Article:
db07-0381v1
db07-0381v2
57/2/306    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, Y. D.
Right arrow Articles by Choi, H.-S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, Y. D.
Right arrow Articles by Choi, H.-S.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Metformin Inhibits Hepatic Gluconeogenesis Through AMP-Activated Protein Kinase–Dependent Regulation of the Orphan Nuclear Receptor SHP

Yong Deuk Kim1, Keun-Gyu Park2, Yong-Soo Lee1, Yun-Yong Park1, Don-Kyu Kim1, Balachandar Nedumaran1, Won Gu Jang3, Won-Jea Cho4, Joohun Ha5, In-Kyu Lee3, Chul-Ho Lee6, and Hueng-Sik Choi1

1 Hormone Research Center, School of Biological Sciences and Technology, Chonnam National University, Gwangju, Republic of Korea
2 Department of Internal Medicine, Keimyung University School of Medicine, Daegu, Republic of Korea
3 Department of Internal Medicine, Kyungpook National University School of Medicine, Daegu, Republic of Korea
4 College of Pharmacy and Research Institute of Drug Development, Chonnam National University, Gwangju, Korea
5 Department of Biochemistry and Molecular Biology, Medical Research Center for Bioreation to Reactive Oxygen Species, Kyung Hee University College of Medicine, Seoul, Republic of Korea
6 Korea Research Institute of Bioscience and Biotechnology, Daejeon, Republic of Korea

Address correspondence and reprint requests to Hueng-Sik Choi, PhD, Hormone Research Center, School of Biological Sciences & Technology, Chonnam National University, Gwangju, 500-757, Republic of Korea. E-mail: hsc{at}chonnam.ac.kr

Abbreviations: ACC, acetyl-CoA carboxylase; Ad-AMPK, adenovirus AMPK; Ad-DN-AMPK, adenovirus dominant negative form of AMPK; Ad-SHP, adenovirus SHP; AICAR, 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside; AMPK, AMP-activated protein kinase; CA-AMPK, constitutively active AMPK; DMEM, Dulbecco's modified Eagle's medium; DN-AMPK, dominant negative mutant AMPK; GAPDH, glyceraldehyde-3-phosphate-dehydrogenase; HNF, hepatocyte nuclear factor; LRH-1, liver receptor homolog-1; SF-1, steroidogenic factor-1; SHP, small heterodimer partner

OBJECTIVE—Metformin is an antidiabetic drug commonly used to treat type 2 diabetes. The aim of the study was to determine whether metformin regulates hepatic gluconeogenesis through the orphan nuclear receptor small heterodimer partner (SHP; NR0B2).

RESEARCH DESIGN AND METHODS—We assessed the regulation of hepatic SHP gene expression by Northern blot analysis with metformin and adenovirus containing a constitutive active form of AMP-activated protein kinase (AMPK) (Ad-AMPK) and evaluated SHP, PEPCK, and G6Pase promoter activities via transient transfection assays in hepatocytes. Knockdown of SHP using siRNA SHP was conducted to characterize the metformin-induced inhibition of hepatic gluconeogenic gene expression in hepatocytes, and metformin–and adenovirus SHP (Ad-SHP)–mediated hepatic glucose production was measured in B6-Lepob/ob mice.

RESULTS—Hepatic SHP gene expression was induced by metformin, 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR), and Ad-AMPK. Metformin-induced SHP gene expression was abolished by adenovirus containing the dominant negative form of AMPK (Ad-DN-AMPK), as well as by compound C. Metformin inhibited hepatocyte nuclear factor-4{alpha}–or FoxA2-mediated promoter activity of PEPCK and G6Pase, and the inhibition was blocked with siRNA SHP. Additionally, SHP knockdown by adenovirus containing siRNA SHP inhibited metformin-mediated repression of cAMP/dexamethasone-induced hepatic gluconeogenic gene expression. Furthermore, oral administration of metformin increased SHP mRNA levels in B6-Lepob/ob mice. Overexpression of SHP by Ad-SHP decreased blood glucose levels and hepatic gluconeogenic gene expression in B6-Lepob/ob mice.

CONCLUSIONS—We have concluded that metformin inhibits hepatic gluconeogenesis through AMPK-dependent regulation of SHP.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2008 by the American Diabetes Association.